Experienced in Splenectomy

Dr. Neil Rellosa

Pediatric Infectious Disease
Nemours Children's Hospital Delaware
1600 Rockland Rd, 
Wilmington, DE 
Experienced in Splenectomy
Nemours Children's Hospital Delaware
1600 Rockland Rd, 
Wilmington, DE 
OverviewInsuranceLocationsClinical Research

Overview

Neil Rellosa is a Pediatric Infectious Disease provider in Wilmington, Delaware. Dr. Rellosa is rated as an Experienced provider by MediFind in Splenectomy. His top areas of expertise are Pneumococcal Meningitis, Congenital Syphilis, H Influenzae Meningitis, Infant Botulism, and Splenectomy.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Splenectomy.

Specialties
Pediatric Infectious Disease
Licenses
Pediatrics in DE
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Nemours Children's Hospital Delaware
1600 Rockland Rd, Wilmington, DE 19803
Other Locations
Nemours Childrens Health Philadelphia
833 Chestnut St Ste 300, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3

6 Total Publications

COVID-19 Vaccine Hesitancy and Refusal:: The Same But Different?
COVID-19 Vaccine Hesitancy and Refusal:: The Same But Different?
Journal: Delaware journal of public health
Published: April 11, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rellosa's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile